Dermatology: Frequently Asked Questions

Dermatology is the branch of medicine concerned with the diagnosis, treatment, and prevention of conditions affecting the skin, hair, nails, and mucous membranes. The field spans medical, surgical, and cosmetic domains, each governed by distinct clinical standards, regulatory frameworks, and professional credentialing requirements. These questions address the core concepts that patients, researchers, and general readers encounter when navigating dermatological care in the United States.

Where can authoritative references be found?

The primary sources for dermatological standards in the United States include the American Academy of Dermatology (AAD), which publishes clinical practice guidelines covering conditions from acne to melanoma, and the American Board of Dermatology (ABD), which governs board certification requirements. The National Institutes of Health (NIH) maintains the National Library of Medicine database, including PubMed, which indexes peer-reviewed dermatology literature. For regulatory matters, the U.S. Food and Drug Administration (FDA) publishes approval records for dermatological drugs, biologics, and devices under 21 CFR. The Centers for Disease Control and Prevention (CDC) provides epidemiological data on skin conditions with public health dimensions, including skin cancer incidence figures. Internationally, the World Health Organization (WHO) classifies skin diseases in the International Classification of Diseases (ICD-11), which U.S. providers adopted for clinical coding. The skin conditions overview page on this site organizes conditions by category with links to condition-specific detail.

How do requirements vary by jurisdiction or context?

Dermatological practice requirements differ across three primary axes: geographic jurisdiction, clinical setting, and payer context. Each U.S. state licenses physicians independently through its medical board; a dermatologist licensed in California is not automatically authorized to practice in Texas. Telemedicine introduces additional complexity — 32 states have enacted telehealth parity laws as of the date of their respective enactments, but interstate practice rules still require licensure in the patient's state in most circumstances. The Federation of State Medical Boards (FSMB) maintains a centralized registry of state-level requirements. Within clinical settings, hospital-based dermatologists operate under institutional credentialing requirements separate from outpatient office standards. Payer context matters for coverage: the Centers for Medicare and Medicaid Services (CMS) distinguishes between medical dermatology procedures covered under Medicare Part B and cosmetic procedures explicitly excluded from coverage under 42 CFR §411.15. For an overview of how these rules affect patients, see dermatology insurance and coverage.

What triggers a formal review or action?

Formal clinical review in dermatology is triggered by a defined set of findings, procedural thresholds, or administrative criteria. Pathology review is mandatory whenever a skin biopsy is performed — the excised tissue must be evaluated by a board-certified dermatopathologist or pathologist before a diagnosis is finalized. The ABD requires Maintenance of Certification (MOC) participation every 10 years for diplomates to retain board-certified status. State medical boards initiate disciplinary review upon receipt of a complaint, an adverse judgment, or a self-reported malpractice settlement above a threshold defined by state statute. Within clinical practice, lesions meeting the ABCDE criteria (Asymmetry, Border irregularity, Color variation, Diameter greater than 6 millimeters, Evolution) trigger mandatory further evaluation under AAD guidelines. Insurance audits are triggered when billing patterns deviate statistically from peer benchmarks under CMS's Targeted Probe and Educate (TPE) program. The skin cancer screening guidelines page details the clinical thresholds used in screening protocols.

How do qualified professionals approach this?

Board-certified dermatologists complete a minimum of 4 years of medical school, 1 year of internship, and 3 years of accredited dermatology residency — a total of at least 8 years of post-undergraduate training — before sitting for the ABD written and procedural examination. Fellowship-trained subspecialists in areas such as Mohs micrographic surgery, pediatric dermatology, or dermatopathology complete 1 to 2 additional years of focused training. During clinical encounters, dermatologists follow a structured sequence: full skin examination, dermoscopic evaluation where indicated, differential diagnosis construction, and — when diagnosis is uncertain — biopsy with histopathological analysis. The AAD's evidence-based clinical practice guidelines, updated on a rolling basis, form the professional standard against which clinical decisions are measured. For a detailed breakdown of professional scope, what dermatologists do outlines the full range of medical, surgical, and procedural services provided. The distinction between generalist and specialist care is covered in dermatologist vs general practitioner.

What should someone know before engaging?

Patients approaching dermatological care for the first time benefit from understanding the triage structure of the specialty. Primary care physicians routinely manage straightforward skin conditions — topical infections, mild acne, and minor rashes — and refer to dermatology when diagnosis is uncertain, first-line treatment has failed, or a lesion raises suspicion for malignancy. Appointment availability varies substantially: a 2022 survey by Merritt Hawkins found median new-patient wait times for dermatology appointments exceeded 32 days in most major U.S. metropolitan areas. Insurance pre-authorization is required for biologics used in conditions such as psoriasis and atopic dermatitis; prior authorization criteria are set by individual payers and typically require documented failure of 2 or more conventional therapies. Patients should bring a list of all current medications, since drug-induced dermatoses are a documented adverse effect class for more than 100 common pharmaceutical agents. The finding a dermatologist in the us page provides guidance on locating board-certified practitioners by location and subspecialty. The site's home page also provides a structured entry point into all major topic areas.

What does this actually cover?

Dermatology as a specialty covers three broad domains. Medical dermatology addresses the diagnosis and treatment of skin diseases, including inflammatory conditions (psoriasis, eczema, rosacea), infectious diseases (fungal infections, impetigo, herpes zoster), autoimmune conditions (lupus, dermatomyositis), and pigmentary disorders (vitiligo, melasma). Surgical dermatology encompasses procedures ranging from standard excisions to Mohs micrographic surgery — a tissue-sparing technique with documented 5-year cure rates exceeding 98% for basal cell carcinoma according to the Skin Cancer Foundation — as well as laser treatments and cryotherapy. Cosmetic dermatology covers procedures without a therapeutic indication, including botulinum toxin injections, dermal fillers, and chemical peels. The boundary between medical and cosmetic dermatology is clinically and legally significant: procedures classified as cosmetic are excluded from insurance coverage, while the same procedure may qualify for coverage when performed for a medical indication. The cosmetic vs medical dermatology page details this classification boundary with procedure-level examples.

What are the most common issues encountered?

The five most frequently diagnosed skin conditions in U.S. ambulatory care settings, based on National Ambulatory Medical Care Survey (NAMCS) data, are acne vulgaris, actinic keratosis, seborrheic keratosis, eczema/atopic dermatitis, and psoriasis. Acne affects an estimated 50 million Americans annually, according to the AAD, making it the most prevalent skin condition in the country. Skin cancer is the most consequential by mortality: melanoma, though representing less than 5% of all skin cancers by incidence, accounts for the majority of skin cancer deaths. Contact dermatitis — divided into irritant contact dermatitis (ICD) and allergic contact dermatitis (ACD) — is the leading occupational skin disease in the United States, documented by the National Institute for Occupational Safety and Health (NIOSH). Hair and nail disorders, including alopecia areata and onychomycosis, represent a substantial share of dermatology referrals. Detailed condition-specific information is available on pages including acne causes and treatment, eczema and atopic dermatitis, psoriasis types and management, and melanoma recognition and risk.

How does classification work in practice?

Dermatological classification operates at three levels: morphological, etiological, and procedural. Morphological classification describes the primary lesion type — macule, papule, plaque, vesicle, pustule, nodule, or wheal — along with secondary changes such as scale, crust, erosion, or ulceration. These descriptors form the foundation of the clinical examination and standardize communication across providers. Etiological classification organizes conditions by underlying mechanism: inflammatory, infectious, neoplastic, genetic, or drug-induced. The ICD-11 chapter on diseases of the skin (Chapter 14) structures billing and epidemiological coding along etiological lines. Procedural classification determines reimbursement: the American Medical Association's Current Procedural Terminology (CPT) code set assigns distinct codes to biopsy techniques (shave, punch, excisional), destruction methods (cryotherapy, laser ablation), and reconstructive procedures, with each code mapped to a relative value unit (RVU) that determines Medicare reimbursement under the Physician Fee Schedule. A shave biopsy of a single lesion (CPT 11102) carries a different reimbursement and documentation requirement than an excisional biopsy with complex repair (CPT 11606 + 13132). For procedure-specific detail, see skin biopsy what to expect and mohs surgery explained.

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)